SARS News and Research

RSS

A knowledgebase of currently known categorized COVID-19 severity variants

In a recent study posted to the medRxiv* preprint server, researchers assessed human genome variants related to the susceptibility and severity of coronavirus disease 2019 (COVID-19).

10 Nov 2022

How long COVID is defined and measured affects prevalence estimation

In a recent study posted to the medRxiv* preprint server, researchers evaluated the prevalence of long coronavirus disease (COVID) symptoms, functional disabilities, symptoms, and pathological alterations among adults and children ≥12 weeks post-acute COVID 2019 (COVID-19).

10 Nov 2022

People of all age groups are at risk of post-COVID-19 syndrome, study says

Following COVID-19 infection, there is significant new onset morbidity in children, adolescents and adults across 13 distinct diagnosis and symptom complexes, according to a new study publishing November 10th in the open access journal PLOS Medicine by Martin Roessler of Technische Universität Dresden, Germany, and colleagues.

10 Nov 2022

Global SARS-CoV-2 infection rates likely to be higher than previously reported

Serosurveillance provides estimates of antibody levels against infectious diseases and is considered the gold standard for measuring population immunity due to past infection or vaccination.

10 Nov 2022

Repeat SARS-CoV-2 infections increase risk of adverse health conditions in multiple organs

Since the COVID-19 pandemic began almost three years ago, scientists have learned that an initial infection can lead to short- and long-term health risks affecting nearly every organ system in the body.

10 Nov 2022

How did alcohol consumption change during the COVID-19 pandemic in the state of Wisconsin?

Researchers evaluated the patterns of alcohol use at three different time points during the SARS-CoV-2 pandemic in Wisconsin.

10 Nov 2022

Researchers demonstrate that neutralizing antibody titers wane over time in ChAdOx1, BNT162b2 and mRNA-1273 vaccinees

Researchers investigated the neutralization antibody titers and the efficacy of the humoral and cellular immunities in individuals vaccinated with three COVID-19 vaccines.

10 Nov 2022

The spectrum of SARS-CoV-2–related neurologic involvement among children and adolescents in 2021

Researchers explored the distribution of severe neurologic involvement in SARS-CoV-2 pediatric patients.

10 Nov 2022

Melatonin could be a potential therapy for long-COVID symptoms

A recent review published in the journal Biomolecules discussed the potential uses of melatonin in treating brain fog, and chronic fatigue syndrome or myalgic encephalomyelitis symptoms associated with long coronavirus disease (COVID)

9 Nov 2022

Empty lipid nanoparticles trigger maturation and activation of antigen-presenting cells

In a recent study posted to the Research Square* preprint server and under review at the Nature Portfolio journal, researchers reported activation and maturation of antigen-presenting cells (APCs) by lipid nanoparticles (LNPs).

9 Nov 2022

Coronavirus exposure reduction strategies in aircraft cabins involving vacant middle seats and masks

In a recent study published in the journal Engineering Reports, researchers evaluated the reduction in exposure to airborne viruses in aircraft cabins when mitigation measures such as mask-wearing and leaving the middle seat vacant were adopted to understand strategies to limit the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during air travel.

9 Nov 2022

COVID-19 vaccination provides higher concentrations of antibodies to babies and pregnant people

Pregnant people who received one of the mRNA COVID-19 vaccines had 10-fold higher antibody concentrations than those who were naturally infected with SARS-CoV-2, a finding that was also observed in their babies, according to a new study by researchers at Children's Hospital of Philadelphia and the University of Pennsylvania.

9 Nov 2022

Long-term effects of SARS-CoV-2 on the brain

More profoundly than previously believed, the virus that causes COVID-19, SARS-CoV-2, can impact the brain for months after infection.

9 Nov 2022

MHRA grants approval for second Pfizer/Biontech bivalent Covid-19 booster vaccine

Approval has today been granted by the Medicines and Healthcare products Regulatory Agency (MHRA) for a Pfizer/BioNTech 'bivalent' Covid vaccine that targets both the Original strain of SARS-CoV-2 and the Omicron BA.4 and BA.5 sub-variants.

9 Nov 2022

Researchers propose a deep antibody-antigen interaction algorithm to accelerate the identification of potential therapeutic antibodies

Researchers used a deep antibody-antigen interaction (DeepAAI) algorithm to understand the antibody representations of unseen antibodies to accelerate the discovery of novel antibodies with potential therapeutic applications.

9 Nov 2022

Mortality rate and risk among hospitalized COVID-19 patients during different surges of the pandemic

Researchers assessed the mortality rates associated with SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) variant infections.

9 Nov 2022

Does fenofibrate improve clinical outcomes in patients with COVID-19?

Researchers assessed the effect of fenofibrate on acute COVID-19.

9 Nov 2022

The direct and indirect effects of COVID-19 on people with type 1 and type 2 diabetes

A recent study published in The Lancet Diabetes & Endocrinology discussed the impact of COVID-19 on individuals with diabetes.

9 Nov 2022

The effect of vaccination-induced immunity on viral loads of SARS-CoV-2 Omicron variant

Researchers analyzed nationwide vaccination data and cycle threshold value data from four laboratories in Israel that conduct SARS-CoV-2 qRT-PCR tests to determine the effect of vaccination-induced immunity on the viral loads of the SARS-CoV-2 Omicron variant.

9 Nov 2022

Study indicates widespread SARS-CoV-2 exposure in wildlife

In a recent study posed to the bioRxiv* preprint server, researchers at Virginia Tech University investigated wildlife exposure to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2).

8 Nov 2022

SARS News and Research

A knowledgebase of currently known categorized COVID-19 severity variants

How long COVID is defined and measured affects prevalence estimation

People of all age groups are at risk of post-COVID-19 syndrome, study says

Global SARS-CoV-2 infection rates likely to be higher than previously reported

Repeat SARS-CoV-2 infections increase risk of adverse health conditions in multiple organs

How did alcohol consumption change during the COVID-19 pandemic in the state of Wisconsin?

Researchers demonstrate that neutralizing antibody titers wane over time in ChAdOx1, BNT162b2 and mRNA-1273 vaccinees

The spectrum of SARS-CoV-2–related neurologic involvement among children and adolescents in 2021

Melatonin could be a potential therapy for long-COVID symptoms

Empty lipid nanoparticles trigger maturation and activation of antigen-presenting cells

Coronavirus exposure reduction strategies in aircraft cabins involving vacant middle seats and masks

COVID-19 vaccination provides higher concentrations of antibodies to babies and pregnant people

Long-term effects of SARS-CoV-2 on the brain

MHRA grants approval for second Pfizer/Biontech bivalent Covid-19 booster vaccine

Researchers propose a deep antibody-antigen interaction algorithm to accelerate the identification of potential therapeutic antibodies

Mortality rate and risk among hospitalized COVID-19 patients during different surges of the pandemic

Does fenofibrate improve clinical outcomes in patients with COVID-19?

The direct and indirect effects of COVID-19 on people with type 1 and type 2 diabetes

The effect of vaccination-induced immunity on viral loads of SARS-CoV-2 Omicron variant

Study indicates widespread SARS-CoV-2 exposure in wildlife

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News